Duopharma Biotech Berhad (KLSE:DPHARMA)
Malaysia · Delayed Price · Currency is MYR 1.330
-0.050 (-3.62%)
At close: Feb 6, 2026
Duopharma Biotech Berhad Market Cap
Duopharma Biotech Berhad has a market cap or net worth of 1.28 billion as of February 6, 2026. Its market cap has increased by 5.56% in one year.
Market Cap
1.28B
Enterprise Value
1.50B
Revenue
900.68M
Ranking
n/a
PE Ratio
15.32
Stock Price
1.33
Market Cap Chart
Since August 27, 2002, Duopharma Biotech Berhad's market cap has increased from 187.00M to 1.28B, an increase of 584.17%. That is a compound annual growth rate of 8.54%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 5, 2026 | 1.33B | 10.40% |
| Dec 31, 2025 | 1.20B | - |
| Dec 31, 2024 | 1.20B | -0.79% |
| Dec 29, 2023 | 1.21B | -20.94% |
| Dec 30, 2022 | 1.53B | -3.10% |
| Dec 31, 2021 | 1.58B | -33.70% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| DXN Holdings Bhd. | 2.46B |
| Kotra Industries Berhad | 605.12M |
| Y.S.P. Southeast Asia Holding Berhad | 296.46M |
| Sunzen Group Berhad | 191.11M |
| Rhone Ma Holdings Berhad | 154.01M |
| Nova Wellness Group Berhad | 114.74M |
| PeterLabs Holdings Berhad | 72.93M |
| Bioalpha Holdings Berhad | 21.10M |